Virus & fertility: when does the barrier break down?

#Virus #BTB #SertoliCells #ViralInfertility    


Long considered an immune-privileged site, the testes are now recognized as a silent yet favored target of several emerging viruses, including Zika, HIV, Ebola and Marburg viruses, and mumps virus. Recent evidence shows that these viral infections can have significant clinical consequences, ranging from fertility disorders to chronic testicular inflammation and even prolonged sexual transmission of the virus.  

Despite these concerns, current treatments focus solely on systemic infection control and fail to specifically target the blood–testis barrier (BTB), which serves as the primary shield for the germinal tissue. This complex structure is the first line of defense against viral invasion into the testicular compartment.  

Many challenges remain: understanding the mechanisms behind BTB disruption, identifying the cellular actors involved, and addressing the lack of reliable preclinical models to replicate these processes.

In this context, the review explores how certain viruses manage to breach the BTB—an often invisible yet critical step in testicular infection.    

Barrier down, virus in?

Human, murine, and non-human primate models were used to investigate how viruses with known testicular tropism invade testicular tissue. The analysis focused on structural and functional changes to the BTB, particularly disruptions to key junctional proteins such as claudins, occludin, and ZO-1. The study also examines interactions between these viruses and Sertoli cells—crucial for BTB integrity—as well as the role of testicular macrophages in modulating local permeability and immune response.  

The findings demonstrate that Zika, HIV, Ebola, Mumps, and Marburg viruses are capable of crossing the BTB after weakening it via the induction of pro-inflammatory cytokines like TNF-α, IL-6, and IFN-γ. Sertoli cells are particularly targeted, leading to disorganization of tight junctions, especially involving ZO-1 and occludin. HIV stands out by producing the Tat protein, which modulates the transcription of genes encoding these junctional proteins, contributing to BTB breakdown.  

The mumps virus—already well-known for causing orchitis—triggers inflammatory cascades that mechanically weaken the BTB. Regarding Zika, several studies report viral persistence in the testes and semen for months, despite an active local immune response. In non-human primates, experimental infections with Ebola and Marburg viruses confirmed the presence of viral particles in Sertoli cells, alongside marked disruption of junctional proteins, indicating effective BTB penetration.    

A chink in the armor

Some viruses exhibit strong testicular tropism, with major clinical consequences such as impaired fertility and prolonged sexual transmission. A key issue lies in understanding how the BTB is disrupted—an essential but poorly understood step enabling viral invasion of germinal tissue.  

This review aimed to shed light on the processes through which certain viruses impair and cross the BTB, facilitating their persistence within the testicular compartment.  

Current findings show that BTB integrity can be compromised by pro-inflammatory cytokines or virus-specific proteins, turning this defensive barrier into a vulnerable entry point. Sertoli cells, central to the maintenance of this immunological frontier, appear to be prime targets for viral attack.  

Several perspectives arise from this work: the development of treatments to restore BTB integrity, the design of ex vivo models specific to testicular tissue, heightened surveillance of emerging viruses with testicular tropism, and the systematic inclusion of reproductive health in epidemic response strategies.